Article
Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II)
23 Jul 2021
Abstract excerpt
INTRODUCTION: High-grade gliomas (HGGs) still have a high rate of recurrence and lethality. Gene therapies were projected to overcome the therapeutic resilience of HGGs, due to the intrinsic genetic heterogenicity and immune evasion pathways. The present literature review strives to provide an updated overview of the novel gene therapies for HGGs treatment, highlighting evidence from clinical trials, molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
